Zeping Zhou

1.1k total citations
59 papers, 499 citations indexed

About

Zeping Zhou is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Zeping Zhou has authored 59 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 12 papers in Genetics and 11 papers in Immunology. Recurrent topics in Zeping Zhou's work include Platelet Disorders and Treatments (40 papers), Blood groups and transfusion (23 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Zeping Zhou is often cited by papers focused on Platelet Disorders and Treatments (40 papers), Blood groups and transfusion (23 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Zeping Zhou collaborates with scholars based in China, United States and United Kingdom. Zeping Zhou's co-authors include Renchi Yang, Huiyuan Li, Donglei Zhang, Zhenping Chen, Feng Xue, Li Ma, Lei Zhang, Jianhui Xu, Weiting Du and Jing Ge and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Zeping Zhou

51 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeping Zhou China 15 356 113 111 109 61 59 499
Ali Amin Asnafi Iran 10 209 0.6× 73 0.6× 40 0.4× 75 0.7× 13 0.2× 35 350
Laura D. Healy United States 12 217 0.6× 95 0.8× 28 0.3× 132 1.2× 25 0.4× 15 442
Yasushi Okoshi Japan 14 167 0.5× 94 0.8× 114 1.0× 231 2.1× 15 0.2× 48 558
N Nagata Japan 10 184 0.5× 113 1.0× 45 0.4× 197 1.8× 14 0.2× 15 497
J F Deschamps France 6 368 1.0× 125 1.1× 25 0.2× 69 0.6× 34 0.6× 7 428
Jun Kuyama Japan 9 198 0.6× 40 0.4× 35 0.3× 101 0.9× 17 0.3× 17 327
MS Gordon United States 5 330 0.9× 82 0.7× 24 0.2× 88 0.8× 18 0.3× 5 461
AM Gewirtz United States 12 383 1.1× 155 1.4× 17 0.2× 93 0.9× 32 0.5× 24 500
Marie Godar Belgium 7 90 0.3× 30 0.3× 58 0.5× 98 0.9× 32 0.5× 7 306
Haraldine A. Stafford United States 12 117 0.3× 63 0.6× 48 0.4× 327 3.0× 21 0.3× 22 578

Countries citing papers authored by Zeping Zhou

Since Specialization
Citations

This map shows the geographic impact of Zeping Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeping Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeping Zhou more than expected).

Fields of papers citing papers by Zeping Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeping Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeping Zhou. The network helps show where Zeping Zhou may publish in the future.

Co-authorship network of co-authors of Zeping Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zeping Zhou. A scholar is included among the top collaborators of Zeping Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeping Zhou. Zeping Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Feng, Tienan Zhu, Zeping Zhou, et al.. (2025). Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials. Nature Medicine. 32(1). 93–102.
2.
Xu, Min, Jing-Ming Guo, Yuping Gong, et al.. (2024). Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study. The Lancet Regional Health - Western Pacific. 47. 101096–101096. 1 indexed citations
3.
4.
Zhou, Zeping, Xingli Zhao, Xinxiao Lu, et al.. (2024). Venetoclax Combined with Three-Day Multi-Frequency Decitabine (DEC3-VEN) in the Treatment of Adult Patients with De Novo Acute Myeloid Leukemia. Blood. 144(Supplement 1). 4279–4279. 1 indexed citations
5.
Wang, Jia, et al.. (2023). Successful hip arthroplasty in a patient with combined deficiency of factor V and factor FVIII. Haemophilia. 30(2). 558–560. 1 indexed citations
6.
Bi, Hui, et al.. (2023). Clinical features and treatment effect of HIV-associated immune thrombocytopenia—single center Ten-Years data summary. Platelets. 34(1). 2200836–2200836. 8 indexed citations
7.
Bi, Hui, et al.. (2023). The novel HLA‐A*68:302 allele, identified by Sanger dideoxynucleotide sequencing in a Chinese individual. HLA. 102(4). 517–519. 2 indexed citations
8.
Wu, Runhui, Xiaoling Wang, Xielan Zhao, et al.. (2022). Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A. Haemophilia. 28(6). e199–e208. 1 indexed citations
9.
Bi, Hui, Hongye Li, Lei-Miao Yin, et al.. (2021). Aberrant Expression of a Proliferation-Inducing Ligand Underlies Autoimmune Mechanisms in Immune Thrombocytopenia. Journal of Immunology Research. 2021. 1–9. 3 indexed citations
10.
11.
Bi, Hui, Lei Zhang, Huiyuan Li, et al.. (2019). Strategy changes in Chinese hematologists’ diagnosis and treatment of primary immune thrombocytopenia across 10 years (2009–2018). Chinese Medical Journal. 132(22). 2749–2750. 1 indexed citations
12.
Tai, Wenlin, et al.. (2018). Inhibitory effect of circulating fibrocytes on injury repair in acute lung injury/acute respiratory distress syndrome mice model. Journal of Cellular Biochemistry. 119(10). 7982–7990. 4 indexed citations
13.
14.
Zhou, Zeping & Renchi Yang. (2011). [Investigation on the strategy of the diagnosis and treatment of primary immune thrombocytopenia in hematological doctor in our country].. PubMed. 32(3). 201–3. 1 indexed citations
15.
Zhou, Hu, Huiyuan Li, Li Ma, et al.. (2011). CD72 gene expression in immune thrombocytopenia. Platelets. 23(8). 638–644. 7 indexed citations
16.
Xu, Jianhui, Ying Huang, Jie Tao, et al.. (2010). An FcγRIIb transmembrane polymorphism in Chinese ITP patients. Platelets. 21(6). 479–485. 6 indexed citations
17.
Qiu, Zhiyong, Shaoguang Yang, Zhenping Chen, et al.. (2008). [Mesenchymal stem cells derived from human umbilical cord tissue modulate the secretion of antiplatelet antibody from splenocytes of ITP patients in vitro].. PubMed. 16(6). 1372–5. 3 indexed citations
18.
Chen, Xiaoli, Jianhui Xu, Zhenping Chen, et al.. (2007). Interferon‐γ +874A/T and interleukin‐4 intron3 VNTR gene polymorphisms in Chinese patients with idiopathic thrombocytopenic purpura. European Journal Of Haematology. 79(3). 191–197. 23 indexed citations
19.
Zhou, Zeping & Renchi Yang. (2007). Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura. Critical Reviews in Oncology/Hematology. 65(1). 21–31. 22 indexed citations
20.
Xu, Jianhui, Shihong Lu, Jie Tao, et al.. (2007). CD72 Polymorphism Associated with Child-Onset of Idiopathic Thrombocytopenic Purpura in Chinese Patients. Journal of Clinical Immunology. 28(3). 214–219. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Amin Asnafi Breakdown of academic impact, for papers by Laura D. Healy Breakdown of academic impact, for papers by Yasushi Okoshi Breakdown of academic impact, for papers by N Nagata Breakdown of academic impact, for papers by J F Deschamps Breakdown of academic impact, for papers by Jun Kuyama Breakdown of academic impact, for papers by MS Gordon Breakdown of academic impact, for papers by AM Gewirtz Breakdown of academic impact, for papers by Marie Godar Breakdown of academic impact, for papers by Haraldine A. Stafford
Rankless by CCL
2026